In just the last month, artificial intelligence (AI) darling Nvidia (NASDAQ: NVDA) has lost roughly $600 billion in market ...

Grew ARR 29% year-over-year to $877 millionExpanded SaaS ARR 39% year-over-year to $540 millionFinished the year with an ~80% year-over-year increase in the number of customers with more than $1 ...

Benchmark indices snapped their seven-day winning streak, as investors turned cautious ahead of the monthly expiry. The S&P ...

Here are the similarities and differences between the 2025 stock market performance and Trump's initial term. Tariff ...

Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians ...

Walmart's strong underlying results, inherent stability, and economies of scale present justify the premium valuation. Find ...

Facing a future tax hit on your retirement savings? A Roth conversion may be a way to lower the taxes you owe.

Follow all the latest U.S. market action for Wednesday here to see if the S&P 500 can extend its three-day winning streak.

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the stock right now. Should you?

Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House ...

This balanced fund goes global, with more international stock and bond exposure than most of its peers. Its equity sleeve ...

AppLovin still has a bright future. From 2024 to 2027, analysts expect its revenue and adjusted EBITDA to grow at a compound ...